Geron Corporation Company Profile

13:55 EDT 21st September 2017 | BioPortfolio

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit

News Articles [91 Associated News Articles listed on BioPortfolio]

Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events

MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...

Geron Shares Dip After J&J Unit-Led Trial Falters, Endo Pops: Biotech Movers

Shares of Geron Corp. were down 5.7% to $2.50 in premarket trading on Tuesday, Aug. 1, after the Menlo Park, Calif.-based firm on Monday gave updates on the development plans for ongoing clinical stud...

Geron: S-L-O-W Progress

Geron: Wishing And Hoping

Geron's Imetelstat: Obstacles To Success

A Look At Geron's Potential Myelofibrosis Competition

A Look At The Competition Geron Could Face In Myelodysplastic Syndromes

Geron Under Pressure as Clinical Trial Changes Causes Delays

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Complex educational and care (geron)technology for elderly individuals/families experiencing Alzheimer's disease.

To describe the contributions of the Integrated Multidisciplinary Care Group for Caregivers of Individuals with Alzheimer's Disease as an educational and care (geron)technology in the context of Alzhe...

Clinical Trials [0 Results]


Companies [178 Associated Companies listed on BioPortfolio]

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The ...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...


Geron Corporation is a biopharmaceutical company focused on discovering and developing therapeutic and diagnostic products to treat cancer and other age-related degenerative diseases. The Company is u...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Geron Corporation" on BioPortfolio

We have published hundreds of Geron Corporation news stories on BioPortfolio along with dozens of Geron Corporation Clinical Trials and PubMed Articles about Geron Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Geron Corporation Companies in our database. You can also find out about relevant Geron Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...

Corporate Database Quicklinks

Searches Linking to this Company Record